Which pharmas need a refresh?

Posted 19 June 2024 AM

Some of the world's richest pharmas are earning the majority of their revenue from drugs that are over 10 years old and heading for patent expiry, but new analysis has exposed which companies have "freshened" their portfolios to replace that income when it disappears. 

Evaluate's 2024 Freshness Index: Who Needs to Freshen Up? looked at the Top 10 companies by revenue from both prescription and over-the-counter drugs in 2023 to find which pharma's revenues are the closest to the cliff and which companies need to freshen up.

To see the whole article, please login